Outlook Therapeutics, Inc. (OTLK) vs Tonix Pharmaceuticals Holding Corp. (TNXP)
Outlook Therapeutics, Inc. and Tonix Pharmaceuticals Holding Corp. are both Biotechnology companies. Outlook Therapeutics, Inc. and Tonix Pharmaceuticals Holding Corp. are of similar size ($166.4M and $159.5M). Tonix Pharmaceuticals Holding Corp. grew revenue faster over the last twelve months: 196.0% against −113.6%. Outlook Therapeutics, Inc. has the higher net margin (5,253.4% vs −548.6%) and the higher return on invested capital (0.00% vs −224.5%). Across the 15 metrics below, Outlook Therapeutics, Inc. leads on 10 and Tonix Pharmaceuticals Holding Corp. on 5.
Valuation
Profitability
| Metric | OTLK | TNXP | Biotechnology median |
|---|---|---|---|
| Gross margin | 195.62% | 83.83% | 65.16% |
| Operating margin | 4,781.76% | (568.43%) | 0.00% |
| Net margin | 5,253.40% | (548.64%) | 0.00% |
| Free cash flow margin | 4,826.38% | (543.29%) | 0.00% |
| Return on equity | 256.92% | (81.82%) | (57.72%) |
| Return on assets | (251.66%) | (72.34%) | (49.22%) |
| Return on invested capital | 0.00% | (224.52%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack